002004 华邦健康
已收盘 10-29 15:00:00
资讯
新帖
简况
华邦健康(002004)10月27日主力资金净买入367.08万元
证券之星 · 10-28 09:12
华邦健康(002004)10月27日主力资金净买入367.08万元
华邦健康(002004)披露2026年三季度报告,10月26日股价下跌0.48%
证券之星 · 10-26
华邦健康(002004)披露2026年三季度报告,10月26日股价下跌0.48%
图解华邦健康三季报:第三季度单季净利润同比下降32.14%
证券之星 · 10-25
图解华邦健康三季报:第三季度单季净利润同比下降32.14%
股市必读:华邦健康新发布《关于全资子公司获得《药品注册证书》的公告》
证券之星 · 10-19
股市必读:华邦健康新发布《关于全资子公司获得《药品注册证书》的公告》
华邦健康(002004)10月15日主力资金净买入324.97万元
证券之星 · 10-16
华邦健康(002004)10月15日主力资金净买入324.97万元
股市必读:华邦健康新发布《关于全资子公司获得《药品注册证书》的公告》
证券之星 · 10-16
股市必读:华邦健康新发布《关于全资子公司获得《药品注册证书》的公告》
华邦健康(002004.SZ):卡左双多巴缓释片获得药品注册证书
智通财经 · 10-15
华邦健康(002004.SZ):卡左双多巴缓释片获得药品注册证书
华邦健康(002004)10月9日主力资金净卖出1275.98万元
证券之星 · 10-12
华邦健康(002004)10月9日主力资金净卖出1275.98万元
10月9日华邦健康涨5.06%,鹏华优质治理LOF基金重仓该股
证券之星 · 10-09
10月9日华邦健康涨5.06%,鹏华优质治理LOF基金重仓该股
股市必读:华邦健康(002004)9月24日董秘有最新回复
证券之星 · 09-28
股市必读:华邦健康(002004)9月24日董秘有最新回复
华邦健康:公司暂未涉及非那雄胺及米诺地尔相关产品
证券之星 · 09-24
华邦健康:公司暂未涉及非那雄胺及米诺地尔相关产品
公司问答丨华邦健康:暂未涉及非那雄胺及米诺地尔相关产品
格隆汇 · 09-16
公司问答丨华邦健康:暂未涉及非那雄胺及米诺地尔相关产品
股市必读:华邦健康(002004)9月14日董秘有最新回复
证券之星 · 09-15
股市必读:华邦健康(002004)9月14日董秘有最新回复
华邦健康(002004)披露2026年中期利润分配预案,9月8日股价上涨2.93%
证券之星 · 09-08
华邦健康(002004)披露2026年中期利润分配预案,9月8日股价上涨2.93%
股市必读:华邦健康(002004)9月3日董秘有最新回复
证券之星 · 09-04
股市必读:华邦健康(002004)9月3日董秘有最新回复
华邦健康:公司将积极通过切实履行信息披露义务、加强投资者沟通等多种方式,持续推动投资价值合理反应公司质量
证券之星 · 09-03
华邦健康:公司将积极通过切实履行信息披露义务、加强投资者沟通等多种方式,持续推动投资价值合理反应公司质量
股市必读:华邦健康新发布《关于控股股东的一致行动人部分股份解除质押的公告》
证券之星 · 08-31
股市必读:华邦健康新发布《关于控股股东的一致行动人部分股份解除质押的公告》
华邦健康(002004)披露控股股东一致行动人部分股份解除质押公告,8月28日股价下跌0.22%
证券之星 · 08-28
华邦健康(002004)披露控股股东一致行动人部分股份解除质押公告,8月28日股价下跌0.22%
华邦健康:乌帕替尼缓释片待专利到期后启动生产和销售
证券之星 · 08-28
华邦健康:乌帕替尼缓释片待专利到期后启动生产和销售
华邦健康:公司计划2026年实施中期分红
证券之星 · 08-28
华邦健康:公司计划2026年实施中期分红
加载更多
公司概况
公司名称:
华邦生命健康股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2004-06-25
主营业务:
华邦生命健康股份有限公司的主营业务是医药制剂及原料药的研发、生产和销售、运营医疗机构,以及从事医疗配套供应链服务、农药原药、中间体及制剂产品的研发、生产、销售、GLP登记注册技术服务及生物技术研究开发、精细化工产品及新型高分子材料的研发、生产和销售、旅游业务。公司的主要产品是医药产品、农化新材料、旅游服务、医疗服务。公司曾荣获“中国医药工业百强企业”等多项荣誉。
发行价格:
9.60
{"stockData":{"symbol":"002004","market":"SZ","secType":"STK","nameCN":"华邦健康","latestPrice":4.25,"timestamp":1793257413000,"preClose":4.2,"halted":0,"volume":22632483,"delay":0,"changeRate":0.0119,"floatShares":1885000000,"shares":1980000000,"eps":0.2891,"marketStatus":"已收盘","change":0.05,"latestTime":"10-29 15:00:00","open":4.2,"high":4.28,"low":4.18,"amount":95830800,"amplitude":0.0238,"askPrice":4.26,"askSize":312,"bidPrice":4.25,"bidSize":215,"shortable":0,"etf":0,"ttmEps":0.2891,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793323800000},"marketStatusCode":5,"adr":0,"adjPreClose":4.2,"symbolType":"stock","openAndCloseTimeList":[[1793237400000,1793244600000],[1793250000000,1793257200000]],"highLimit":4.62,"lowLimit":3.78,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1979919191,"isCdr":false,"pbRate":0.83,"roa":"--","peRate":14.700796,"roe":"4.62%","epsLYR":0.3615,"committee":-0.505017,"marketValue":8415000000,"turnoverRate":0.012,"status":0,"floatMarketCap":8013000000},"requestUrl":"/m/hq/s/002004","defaultTab":"news","newsList":[{"id":"2678438468","title":"华邦健康(002004)10月27日主力资金净买入367.08万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678438468","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678438468?lang=zh_cn&edition=full","pubTime":"2026-10-28 09:12","pubTimestamp":1793149924,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月27日收盘,华邦健康报收于4.19元,上涨0.0%,换手率1.01%,成交量19.06万手,成交额8016.58万元。近5日资金流向一览见下表:华邦健康融资融券信息显示,融资方面,当日融资买入419.02万元,融资偿还595.75万元,融资净偿还176.73万元。融券方面,融券卖出1.14万股,融券偿还1800.0股,融券余量101.09万股,融券余额423.57万元。华邦健康主营业务:涵盖医药、医疗、农化、新材料、旅游等五大领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800015175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0174","BK0042","BK0188","BK0229","002004","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678164801","title":"华邦健康(002004)披露2026年三季度报告,10月26日股价下跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678164801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678164801?lang=zh_cn&edition=full","pubTime":"2026-10-26 18:15","pubTimestamp":1793009727,"startTime":"0","endTime":"0","summary":"截至2026年10月26日收盘,华邦健康报收于4.19元,较前一交易日下跌0.48%,最新总市值为82.96亿元。公司于近日披露《2026年三季度报告》。报告显示,2026年第三季度营业收入2,806,479,355.92元,同比下降10.65%;归属于上市公司股东的净利润151,571,170.01元,同比下降32.14%。年初至报告期末营业收入8,716,372,736.07元,同比下降4.07%;归属于上市公司股东的净利润470,917,184.87元,同比下降23.03%。基本每股收益0.2387元,同比下降23.02%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600025644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","002004","BK0146","BK0174","BK0114","BK0229","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678187607","title":"图解华邦健康三季报:第三季度单季净利润同比下降32.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678187607","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678187607?lang=zh_cn&edition=full","pubTime":"2026-10-25 16:45","pubTimestamp":1792917928,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康2026年三季报显示,前三季度公司主营收入87.16亿元,同比下降4.07%;归母净利润4.71亿元,同比下降23.03%;扣非净利润4.8亿元,同比下降13.14%;其中2026年第三季度,公司单季度主营收入28.06亿元,同比下降10.65%;单季度归母净利润1.52亿元,同比下降32.14%;单季度扣非净利润1.8亿元,同比下降12.2%;负债率40.93%,投资收益3150.77万元,财务费用2.23亿元,毛利率38.62%。财报数据概要请见下图:本文数据来源于华邦健康2026年三季报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102500004413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002004"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676088578","title":"股市必读:华邦健康新发布《关于全资子公司获得《药品注册证书》的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2676088578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676088578?lang=zh_cn&edition=full","pubTime":"2026-10-19 02:17","pubTimestamp":1792347429,"startTime":"0","endTime":"0","summary":"公司公告汇总:全资子公司重庆华邦制药获卡左双多巴缓释片《药品注册证书》,注册分类为化学药品4类,视同通过仿制药质量和疗效一致性评价。公司公告汇总关于全资子公司获得《药品注册证书》的公告华邦生命健康股份有限公司全资子公司重庆华邦制药有限公司近日收到国家药品监督管理局核准签发的卡左双多巴缓释片《药品注册证书》。审批结论为符合药品注册有关要求,批准注册。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0174","BK0114","BK0042","BK0188","BK0229","002004"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675551479","title":"华邦健康(002004)10月15日主力资金净买入324.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675551479","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675551479?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:09","pubTimestamp":1792112962,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月15日收盘,华邦健康报收于4.34元,下跌0.46%,换手率1.16%,成交量21.81万手,成交额9455.45万元。近5日资金流向一览见下表:华邦健康融资融券信息显示,融资方面,当日融资买入888.2万元,融资偿还818.81万元,融资净买入69.39万元,连续3日净买入累计1491.79万元。华邦健康主营业务:涵盖医药、医疗、农化、新材料、旅游等五大领域。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600008790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0174","BK0114","BK0146","BK0188","BK0229","002004"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675837532","title":"股市必读:华邦健康新发布《关于全资子公司获得《药品注册证书》的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675837532","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675837532?lang=zh_cn&edition=full","pubTime":"2026-10-16 02:42","pubTimestamp":1792089731,"startTime":"0","endTime":"0","summary":"公司公告汇总:全资子公司重庆华邦制药获卡左双多巴缓释片《药品注册证书》,注册分类为化学药品4类,视同通过仿制药质量和疗效一致性评价。公司公告汇总关于全资子公司获得《药品注册证书》的公告华邦生命健康股份有限公司全资子公司重庆华邦制药有限公司近日收到国家药品监督管理局核准签发的卡左双多巴缓释片《药品注册证书》。审批结论为符合药品注册有关要求,批准注册。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600002495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002004","BK0114","BK0174","BK0042","BK0188","BK0229","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675586694","title":"华邦健康(002004.SZ):卡左双多巴缓释片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2675586694","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675586694?lang=zh_cn&edition=full","pubTime":"2026-10-15 18:49","pubTimestamp":1792061346,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华邦健康(002004.SZ)发布公告,公司全资子公司重庆华邦制药有限公司于近日收到国家药品监督管理局核准签发的关于卡左双多巴缓释片的《药品注册证书》。卡左双多巴缓释片按化学药品4类申报,视同通过仿制药质量和疗效一致性评价。该产品的正式获批,将进一步丰富公司在帕金森病治疗领域的产品管线布局,同时为临床患者提供更多优质用药选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华邦健康(002004.SZ):卡左双多巴缓释片获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","002004","BK0174","BK0042","BK0114","BK0229","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674847532","title":"华邦健康(002004)10月9日主力资金净卖出1275.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674847532","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674847532?lang=zh_cn&edition=full","pubTime":"2026-10-12 09:06","pubTimestamp":1791767217,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月9日收盘,华邦健康报收于4.57元,上涨5.06%,换手率2.9%,成交量54.62万手,成交额2.45亿元。近5日资金流向一览见下表:华邦健康融资融券信息显示,融资方面,当日融资买入1731.49万元,融资偿还2439.72万元,融资净偿还708.24万元。华邦健康主营业务:农药、医药、化学原料药、医疗健康、旅游服务业等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200002888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002004","BK0174","BK0042","BK0146","BK0114","BK0188","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674683240","title":"10月9日华邦健康涨5.06%,鹏华优质治理LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674683240","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674683240?lang=zh_cn&edition=full","pubTime":"2026-10-09 16:39","pubTimestamp":1791535159,"startTime":"0","endTime":"0","summary":"证券之星消息,10月9日华邦健康涨5.06%,收盘报4.57元,换手率2.9%,成交量54.62万手,成交额2.45亿元。重仓华邦健康的公募基金请见下表:根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为鹏华基金的鹏华优质治理LOF。鹏华优质治理LOF的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900025715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0042","BK0229","BK0188","BK0174","002004","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670092194","title":"股市必读:华邦健康(002004)9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2670092194","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670092194?lang=zh_cn&edition=full","pubTime":"2026-09-28 02:19","pubTimestamp":1790533150,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘,华邦健康报收于4.3元,下跌1.6%,换手率0.9%,成交量16.99万手,成交额7349.11万元。当日关注点交易信息汇总:9月24日主力资金净流出543.72万元,占总成交额7.4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002004","BK0114","BK0174","BK0042","BK0188","BK0229","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669506456","title":"华邦健康:公司暂未涉及非那雄胺及米诺地尔相关产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2669506456","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669506456?lang=zh_cn&edition=full","pubTime":"2026-09-24 11:36","pubTimestamp":1790220979,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康(002004)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问:贵司有皮肤科处方药非常好的广泛渠道,建议拓展市场天花板很高的生发药,先做指南上的药品,仿制米诺地尔和非那雄胺,但改变剂型,市场上暂时没有的,例如口服缓释胶囊,外用的凝胶剂;再投入研发一类生发创新药。华邦健康回复:投资者您好,公司暂未涉及非那雄胺及米诺地尔相关产品,但生发领域是公司关注的方向之一。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400016862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0174","BK0042","002004","BK0114","BK0146","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667606946","title":"公司问答丨华邦健康:暂未涉及非那雄胺及米诺地尔相关产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2667606946","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667606946?lang=zh_cn&edition=full","pubTime":"2026-09-16 16:33","pubTimestamp":1789547600,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0042","BK0188","BK0174","BK0146","002004","BK0229","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667660953","title":"股市必读:华邦健康(002004)9月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2667660953","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667660953?lang=zh_cn&edition=full","pubTime":"2026-09-15 00:51","pubTimestamp":1789404671,"startTime":"0","endTime":"0","summary":"截至2026年9月14日收盘,华邦健康报收于4.45元,上涨1.83%,换手率1.93%,成交量36.39万手,成交额1.6亿元。董秘最新回复投资者: 有皮肤科药的销售渠道,建议生产头发外用药,米诺地尔+非那雄胺外用喷剂组合装+红外导液梳,这两个药价格贵,患者多。当日关注点交易信息汇总:9月14日主力资金净流入122.63万元,占总成交额0.76%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500000491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0174","BK0146","BK0042","002004","BK0188","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665321666","title":"华邦健康(002004)披露2026年中期利润分配预案,9月8日股价上涨2.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665321666","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665321666?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:59","pubTimestamp":1788861571,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘,华邦健康报收于4.57元,较前一交易日上涨2.93%,最新总市值为90.48亿元。近日,华邦生命健康股份有限公司发布2026年第二次临时股东会决议公告。公告显示,公司于2026年9月7日召开2026年第二次临时股东会,会议审议通过《2026年中期利润分配预案》。出席会议股东共399人,代表股份527,357,079股,占公司有表决权总股份的26.7307%;表决结果为同意526,070,379股,占99.7560%;反对1,236,000股,占0.2344%;弃权50,700股,占0.0096%。中小股东对该议案的同意率为97.8841%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002004","BK0114","BK0188","BK0146","BK0042","BK0229","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664980698","title":"股市必读:华邦健康(002004)9月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2664980698","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664980698?lang=zh_cn&edition=full","pubTime":"2026-09-04 02:05","pubTimestamp":1788458716,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘,华邦健康报收于4.43元,下跌1.12%,换手率0.91%,成交量17.16万手,成交额7668.8万元。董秘最新回复投资者: 公司股价一直低迷,应该做好市值管理提高市场知名度有比,更有利于皮肤方面的相关产品销售和推广。公司高度重视市值管理,但股价受宏观环境、市场情绪及投资者偏好等多种因素共同影响。当日关注点交易信息汇总:9月3日主力资金净流出164.87万元,占总成交额2.15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400002436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0114","BK0229","BK0188","BK0174","002004","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664165840","title":"华邦健康:公司将积极通过切实履行信息披露义务、加强投资者沟通等多种方式,持续推动投资价值合理反应公司质量","url":"https://stock-news.laohu8.com/highlight/detail?id=2664165840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664165840?lang=zh_cn&edition=full","pubTime":"2026-09-03 09:12","pubTimestamp":1788397970,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康(002004)09月03日在投资者关系平台上答复投资者关心的问题。投资者提问:公司股价一直低迷,应该做好市值管理提高市场知名度有比,更有利于皮肤方面的相关产品销售和推广。华邦健康回复:投资者您好,感谢您的建议。公司高度重视市值管理,但股价受宏观环境、市场情绪及投资者偏好等多种因素共同影响。未来,公司将积极通过切实履行信息披露义务、加强投资者沟通等多种方式,持续推动投资价值合理反应公司质量。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300008814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","BK0114","BK0146","BK0042","BK0188","002004","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663023817","title":"股市必读:华邦健康新发布《关于控股股东的一致行动人部分股份解除质押的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663023817","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663023817?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:32","pubTimestamp":1788136330,"startTime":"0","endTime":"0","summary":"公司公告汇总:控股股东一致行动人张一卓先生解除质押22,080,000股,占公司总股本1.12%,解除后其累计质押股份数量为0。本次解除质押的股份原质押给渤海国际信托股份有限公司,质押起始日为2025年10月24日,解除质押日期为2026年8月27日。公司已取得中国证券登记结算有限责任公司出具的相关解除质押登记通知及证券质押明细表。乌帕替尼缓释片申报时提交了3类专利声明,待涉及的专利有效期到期后,公司将尽快启动生产和销售工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100002359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0188","002004","BK0174","BK0042","BK0229","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662915860","title":"华邦健康(002004)披露控股股东一致行动人部分股份解除质押公告,8月28日股价下跌0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662915860","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662915860?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:24","pubTimestamp":1787927068,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,华邦健康报收于4.55元,较前一交易日下跌0.22%,最新总市值为90.09亿元。近日,华邦生命健康股份有限公司发布公告称,公司控股股东的一致行动人张一卓先生将其持有的22,080,000股公司股份办理了解除质押手续,占其所持股份比例的40.10%,占公司总股本的1.12%。本次解除质押的股份原质押给渤海国际信托股份有限公司,质押起始日为2025年10月24日,解除质押日期为2026年8月27日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800054858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0188","BK0042","002004","BK0114","BK0229","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662169057","title":"华邦健康:乌帕替尼缓释片待专利到期后启动生产和销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2662169057","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662169057?lang=zh_cn&edition=full","pubTime":"2026-08-28 15:54","pubTimestamp":1787903647,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康08月28日在投资者关系平台上答复投资者关心的问题。请回答下谢谢华邦健康回复:投资者您好,公司整体经营稳健,也在积极通过切实履行信息披露义务、加强投资者沟通等多种方式,持续推动投资价值合理反应公司质量,但公司股价受宏观环境、市场情绪及投资者偏好等多种因素共同影响。乌帕替尼缓释片申报时提交了3类专利声明,待涉及的专利有效期到期后,公司将尽快启动生产和销售工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800033926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0042","BK0114","002004","BK0146","BK0188","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662905320","title":"华邦健康:公司计划2026年实施中期分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2662905320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662905320?lang=zh_cn&edition=full","pubTime":"2026-08-28 11:48","pubTimestamp":1787888886,"startTime":"0","endTime":"0","summary":"证券之星消息,华邦健康08月27日在投资者关系平台上答复投资者关心的问题。公司高度重视股东回报,多年保持高比例分红,未来也将积极考虑保持可持续的利润分配政策。同时,公司计划2026年实施中期分红,拟向全体股东每10股派发现金红利1.0元(含税)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800024718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002004","BK0114","BK0188","BK0146","BK0042","BK0229","BK0174"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793305678853,"stockEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":-0.0023},{"period":"3month","weight":-0.0189},{"period":"6month","weight":-0.0761},{"period":"1year","weight":-0.0725},{"period":"ytd","weight":-0.0393}],"compareEarnings":[{"period":"1week","weight":-0.0018},{"period":"1month","weight":-0.0467},{"period":"3month","weight":-0.0472},{"period":"6month","weight":-0.112},{"period":"1year","weight":-0.0909},{"period":"ytd","weight":-0.08}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华邦生命健康股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"71414人(较上一季度减少60.21%)","perCapita":"26400股","listingDate":"2004-06-25","address":"重庆市两江新区大竹林街道人和星光大道69号","registeredCapital":"197991万元","survey":" 华邦生命健康股份有限公司的主营业务是医药制剂及原料药的研发、生产和销售、运营医疗机构,以及从事医疗配套供应链服务、农药原药、中间体及制剂产品的研发、生产、销售、GLP登记注册技术服务及生物技术研究开发、精细化工产品及新型高分子材料的研发、生产和销售、旅游业务。公司的主要产品是医药产品、农化新材料、旅游服务、医疗服务。公司曾荣获“中国医药工业百强企业”等多项荣誉。","listedPrice":9.6},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华邦健康(002004)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华邦健康(002004)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华邦健康,002004,华邦健康股票,华邦健康股票老虎,华邦健康股票老虎国际,华邦健康行情,华邦健康股票行情,华邦健康股价,华邦健康股市,华邦健康股票价格,华邦健康股票交易,华邦健康股票购买,华邦健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华邦健康(002004)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华邦健康(002004)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}